2017
DOI: 10.1515/med-2017-0039
|View full text |Cite
|
Sign up to set email alerts
|

The diagnostic accuracy of conventional forceps biopsy compared to ESD

Abstract: AbstractObjectiveconventional forceps biopsy (CFB) is the most popular way to screen for gastric epithelial neoplasia (GEN). Our study aimed to compare the diagnostic accuracy between conventional forceps biopsy and endoscopic submucosal dissection (ESD).Methods105 pati… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
4
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(4 citation statements)
references
References 8 publications
0
4
0
Order By: Relevance
“…Based on the results of the present study, our recommendation is that for any visible lesions with a EFB disclosing LGD, the clinician should discuss carefully with the endoscopist and pathologist on a case-by-case basis, considering endoscopic characteristics, patients status and offering the patient endoscopic resection, preferentially by ESD if lesion size is greater than 15 mm. It provides a definitive therapeutic approach that eradicates this type of lesions, enables a reliable histopathologic assessment and therefore eliminating the risk of oncologic progression 24–26. This management algorithm is aligned with recent international guidelines proposing immediate endoscopic resection of dysplastic and neoplastic endoscopically visible lesions 27–30.…”
Section: Discussionmentioning
confidence: 93%
See 2 more Smart Citations
“…Based on the results of the present study, our recommendation is that for any visible lesions with a EFB disclosing LGD, the clinician should discuss carefully with the endoscopist and pathologist on a case-by-case basis, considering endoscopic characteristics, patients status and offering the patient endoscopic resection, preferentially by ESD if lesion size is greater than 15 mm. It provides a definitive therapeutic approach that eradicates this type of lesions, enables a reliable histopathologic assessment and therefore eliminating the risk of oncologic progression 24–26. This management algorithm is aligned with recent international guidelines proposing immediate endoscopic resection of dysplastic and neoplastic endoscopically visible lesions 27–30.…”
Section: Discussionmentioning
confidence: 93%
“…It provides a definitive therapeutic approach that eradicates this type of lesions, enables a reliable histopathologic assessment and therefore eliminating the risk of oncologic progression. [24][25][26] This management algorithm is aligned with recent international guidelines proposing immediate endoscopic resection of dysplastic and neoplastic endoscopically visible lesions. [27][28][29][30] Pimentel-Nunes et al 31 in the latest guideline of MAPS II proposed by the European Society of Gastrointestinal Endoscopy established the current standards for the management of pre-neoplastic gastric lesions; highlighting that endoscopically visible dysplasia detected by high quality endoscopic techniques (chromoendoscopy/endoscopic magnification) should be eradicated after the endoscopic diagnosis due to the high risk of oncological progression to adenocarcinoma, and that close surveillance should be reserved only for patients with histopathologic diagnosis of dysplasia without an endoscopically visible focal lesion (LGD: every 12 mo; HGD: every 6 mo).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The association between ulceration and LGIN upgrade diagnosis risk was assessed in six articles [5,8,10,11,15,16,18] . The pooled OR between ulceration and LGIN upgrade diagnosis was 1(95%CI).…”
Section: Ulcerationmentioning
confidence: 99%